AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Former Intel CEO Pat Gelsinger reinvents himself as an angel investor in AI startup Fractile
2
5 cybersecurity trends and startups to watch in 2025
3
"Everyone will be a manager" - what the world of work will look like with AI agents
4
Eleos doubles in value as it raises $60 million to disrupt behavioral healthcare
5
AppsFlyer appoints new Chief Business Officer amid IPO speculation
More news

Kadimastem

2 stories about Kadimastem
default image

Israeli and French Biotech Companies Partner to Fight Diabetes With Bio-Artificial Pancreas

12.11.18|Lilach Baumer
Israel-based Kadimastem and France-headquartered Defymed will receive a grant of around $1.5 million from the European Commission's Eurostars program to develop the technology to treat type 1 diabetes
default image

Kadimastem Gets FDA Orphan Drug Designation for ALS Drug

04.11.18|Lilach Baumer
The biotech company is currently conducting an early clinical trial in Israel and expects results in mid-2019